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A new leukoencephalopathy with 
vanishing white matter
M.S. van der Knaap, MD, PhD; P.G. Barth, MD, PhD; F.J.M. Gabreëls, MD, PhD; E. Franzoni, MD;
J.H. Begeer, MD, PhD; H. Stroink, MD; J.J. Rotteveel, MD, PhD; and J. Valk, MD, PhD
Article abstract—We identified nine children with a leukoencephalopathy of similar type according to clinical and MRI 
findings. The patients included three affected sibling pairs. The age range was 3 to 19 years. The onset of the disease was 
in childhood; the course was both chronic-progressive and episodic, There were episodes of deterioration following 
infections and minor head traumas, and these could result in unexplained coma. In eight patients with advanced disease, 
MRI revealed a diffuse cerebral hemispheric leukoencephalopathy, in which increasing areas of the abnormal white 
matter had a signal intensity close to that of CSF on all pulse sequences. In one patient in the early stages of disease, 
initial MRI showed diffusely abnormal cerebral white matter, which only reached the signal characteristics of CSF at a 
later stage. In the patients in whom the disease was advanced, magnetic resonance spectroscopy (MRS) of the white 
matter showed an almost complete disappearance of all normal signals and the presence of glucose and lactate, compatible 
with the presence of mainly CSF and little brain tissue. Spectra of the cortex were much better preserved. However, in 
addition to the normal resonances, there were signals representing lactate and glucose. MRS of the white matter in the 
patient whose disease was at an early stage was much less abnormal. Autopsy in one patient confirmed the presence of 
extensive cystic degeneration of the cerebral white matter with reactive change and a preserved cortex. Typical involve­
ment of pontine tegmental white matter was suggested by MRI and confirmed by autopsy. The disease probably has an 
autosomal recessive mode of inheritance, but the basic metabolic defect is not known.
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There is a growing number of progressive encepha­
lopathies identified and defined by enzyme defect, 
gene defect, or both.1 MRI has contributed consider­
ably to the detection of leukoencephalopathies,2 but a 
significant proportion remains unclassified.3 In some 
cases, MRI and magnetic resonance spectroscopy 
(MRS) findings are sufficiently distinct to be used as 
criteria for a classifying diagnosis.4
As part of an ongoing study of unclassified leu­
koencephalopathies, we identified nine patients with 
a distinct disorder, as defined by clinical and MRI 
criteria. We describe the clinical picture, metabolic 
investigations, and neurophysiologic studies, as well 
as MRI, MRS, and autopsy findings, and provide 
criteria for the diagnosis.
Methods. Clinical history, neurologic findings, biochemi­
cal tests, and neurophysiologic studies were documented.
All nine patients underwent MRI, six of them on two 
occasions. In all patients, ^-weighted (TXW), proton- 
density (PD), and T2-weighted (T2W) images were made. 
The images were evaluated for the localization and appear­
ance of white-matter abnormalities and the presence of 
gray-matter lesions with the help of a standardized scoring 
list (see reference 5 for details).
Proton ^H) MRS was performed in five patients (pa­
tients 3, 4, 5, 7, and 9) with the standard imaging head 
coil. We used single-voxel spectroscopy in order to achieve 
a high-quality assessment of the neurochemical composi­
tion of white matter versus cortex. A 2 X 2 X 2 cm3 voxel 
was chosen in the mid-occipital area, containing mainly 
occipital cortex of both hemispheres and some white mat­
ter and CSF. Another voxel of 2 X 2 X 2 cm3 was chosen in 
the parieto-occipital area, containing white matter and, at 
most, some ventricular CSF. The spectra were acquired 
with use of the PRESS sequence, with a repetition time of
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2,500 msec, echo times of 135 and 270 msec, and 128 
acquisitions (see reference 6 for technical details), and the 
STEAM sequence, with a repetition time of 2,500 msec, an 
echo time of 20 msec, and 128 acquisitions (see reference 7 
for technical details). Another procedure was used in pa­
tient 9 only. MR spectra were obtained from three 2 X 2 X 
2 cm3 voxels in the left frontal and left and right occipital 
white matter, with use of the PRESS sequence with an 
echo time of 135 msec. The averaged measurements were 
zero-filled to 2,048 data points, exponentially filtered to 
give 1-Hz line-broadening before fast-Fourier transforma­
tion. The spectra were quantified by peak area measure­
ments with system software (Siemens SP 63). Ratios of 
concentrations of metabolites were calculated relative to 
creatine (Cr). We did not convert these ratios into “abso­
lute” concentrations with the help of known Cr or tissue 
water concentrations, as, considering the extent of tissue 
damage and loss, all metabolites, including Cr, were prob­
ably considerably decreased and tissue water highly in­
creased.
Autopsy was performed in patient 2. The brain and 
spinal cord were fixed in 4% formaldehyde. For histopatho­
logic examination, paraffin sections were stained with 
hematoxylin-eosin, Luxol fast blue, Nissl, Sudan black, 
Kluver, and Bodian stain. In addition, immunostaining 
was performed for myelin basic protein (MBP), glial fibril­
lary acidic protein (GFAP), neurofilament, and neuron- 
specific enolase (NSE).
Results* Clinical profiles. The clinical data are summa­
rized in table 1. A full description of two representative 
patients is presented below.
Patient 1 is a female, born in March 1987, first child of 
healthy, unrelated parents. Initial psychomotor develop­
ment was normal. She could walk independently at the age 
of 15 months, but her gait was never quite stable. At the 
age of 2Y2 years, motor coordination deteriorated within 
the course of a few weeks. She stopped speaking. Recur­
rent vomiting occurred. Behavioral changes were present 
with irritability and screaming. The girl became apathetic, 
somnolent, and, finally, comatose. Over a period of a few 
months she made a partial recovery. The subsequent 
course of the disease was characterized by episodic deteri­
oration following minor infections, usually of the upper 
respiratory tract, accompanied by fever. During these epi­
sodes, she sometimes had tonic-clonic seizures. On several 
occasions, the deterioration led to recurrent vomiting and 
lowering of consciousness. She died in November 1993 dur­
ing her fourth coma, which followed a urinary tract infec­
tion with fever.
The neurologic findings in the course of her disease 
included normal eye movements, no nystagmus, prominent 
cerebellar ataxia, dysarthria, and some spasticity with 
brisk tendon reflexes and extensor plantar reflexes. She 
remained nor mo cephalic. She developed optic atrophy at 
the age of 5 years. There was no clinical evidence of pe­
ripheral nerve involvement. Mental functions were better 
preserved than motor functions.
Patient 2 is the younger sister of patient 1, born in 
August 1989. Her psychomotor development was slightly 
retarded. She walked independently at the age of 2 years. 
Her gait was mildly unstable and gradually deteriorated 
within a matter of months. At the age of 2Vfe years, she fell 
off the couch and was unconscious for a few minutes. On
regaining consciousness, her gait had become less stable. 
She recovered within a few weeks. Another fall from the 
couch 3 months later immediately resulted in decreased 
stability and loss of the ability to walk independently, 
which she never regained. The subsequent course of dis­
ease was characterized by chronic-progressive and some­
times stepwise deterioration of motor coordination and vi­
sion, but she did not suffer episodes of major deterioration 
or coma. She had infrequent epileptic seizures. In April 
1995 she had a minor upper respiratory tract infection, 
which was followed by rapid deterioration and loss of mo­
tor function, frequent vomiting, epileptic seizures, and 
coma. She died in June 1995 after prolonged coma.
The neurologic findings in the course of her disease 
included normal eye movements, no nystagmus, severe 
cerebellar ataxia, and some spasticity with brisk tendon 
reflexes. Head circumference was normal. She developed 
optic atrophy at the age of 4 years. There was no clinical 
evidence of peripheral nerve involvement, and mental 
functions were relatively preserved.
Laboratory investigations. Many of the laboratory 
tests were performed only in the first of two affected sib­
lings within one family.
In all patients, routine blood tests with assessment of 
liver function, renal function, glucose, capillary blood 
gases, calcium, and phosphate were normal. There was no 
evidence of an autoimmune disorder (patient 1). Lumbar 
puncture, performed either during an episode of coma or 
subcoma (patients 1, 3, 5, and 7) or in a period of relative 
stability (patients 2, 5, 6, 7, 8, and 9) revealed normal CSF 
protein level, cell count, glucose, IgG index, lactate, and 
pyruvate, and no evidence of oligoclonal banding. Some 
elevation of CSF lactate was found only in patients 3 and 7 
during episodes of deterioration, but the level returned to 
normal as they improved. In patient 1, some elevation of 
CSF protein was found once during an episode of deterio­
ration. CSF level of MBP was normal in patient 3 and 
elevated during a period of deterioration in patient 7, re­
turning to normal after clinical improvement. CSF GAB A 
(patient 2) and 5-HIAA and HVA (patients 3 and 7) were 
normal. Active infection with Borrelia burgdorferi (pa­
tients 1 and 7), neurotropic viruses (patients 1, 3, 7, and 8), 
and Mycoplasma pneumoniae (patients 3 and 7) was ex­
cluded by analysis of blood and CSF. Vitamin B l3 B2 (pa­
tient 1), B12 (patients 1 and 7), folic acid (patient 7), and 
vitamin E levels (patients 1 and 6) were normal. No evi­
dence of thyroid dysfunction (patients 1, 3 , 6, and 7), adre­
nal dysfunction (patients 3, 5, 6, and 7), or gonadal dys­
function (patient 3, age 19 years) was found. Serum levels 
of copper and ceruloplasmin were normal (patients 1, 3, 6, 
and 7). Metabolic screening of a 24-hour sample of urine, 
with assessment of amino acids, organic acids, oligosaccha­
rides, monosaccharides, disaccharides, mucopolysacchar­
ides, purines, and pyrimidines, was normal in all patients, 
with the exception of patient 5 (see below). Amino acids in 
plasma were normal. Serum levels of ammonia, lactate, 
pyruvate, acetoacetate, 3-hydroxybutyrate, and carnitine 
were normal in all patients with the exception of patient 7 
(see below). Transferrin focusing of blood samples revealed 
a normal subfraction distribution (patients 3, 4 , and 7). 
Assessment of lysosomal enzymes in leukocytes, in partic­
ular arylsulfatase A, galactocerebroside p-galactosidase,
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T able 1 Clinical history and present findings
Patient
Sex
Affected sibling 
Unaffected siblings 
Consanguinity of parents 
Present age (yr)
Age at 1st MRI (yr)
Age at 2nd MRI (yr)
Initial motor development 
Walking (mo)
Initial mental development
Onset of motor deterioration (yr) 
Loss of walking (yr)
Type of deterioration 
Episodic 
Chronic 
Comas
Provoking factors 
Infections 
Head traumas 
Epilepsy 
Motor signs 
Ataxia 
Spasticity 
Mental capacities 
Optic atrophy
Head circumference 
Abnormalities internal organs
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Table 2 lH MRS findings, as obtained from the cortex voxel
PRESS 135 spectra STEAM 20 spectra
Age (yr) NAA/Cr Cho/Cr NAA/Cr Cho/Cr mlno/C
Patient
3 18 1.45 0.67 1.32 0,58 0.60
4 15 1.57 0.83 1.45 0.70 0.52
5 12 1.35 0.79 1.23 0.69 0,58
7 9 1.25 0.85 1.18 0.76 0.62
Control
1 8 1.72 0.73 1.57 0.59 0.64
2 12 1.76 0.68 1.50 0.54 0.59
3 17 1.70 0,70 1.63 0,59 0.68
der. In other patients, the ventricular lining was quite 
clear, whereas all or most of the white matter was other­
wise indistinguishable from CSF (see figure 2). In some 
patients, a fine mesh work of residual strands of brain tissue 
was seen in the areas of CSF-like white matter (figure 1A).
Only the first MRI of patient 9, obtained before the 
development of somatic neurologic abnormalities, was dif­
ferent. The cerebral white matter had a homogeneous high 
signal intensity on both PD and T2W images, Repeat MRI 
obtained after onset of somatic neurologic deterioration 
showed that parts of the cerebral white matter now had a 
lower signal intensity on PD images, close to that of CSF,
In most patients, the white matter appeared mildly 
swollen with some broadening of gyri, particularly in pa­
tient 5 (see figure 2). The lateral ventricles were mildly to 
moderately enlarged in patients 3, 4, and 5, but they were 
normal in the others. The inner rim of the corpus callosum 
was involved in all patients except patient 3, whereas the 
outer rim of the corpus callosum was spared in all but 
patient 5. The posterior limb of the internal capsule was 
affected in patients 1, 5, 7, and 8; the anterior limb was 
spared in all patients. The signal intensity of the cerebel­
lar white matter was mildly elevated in all patients on 
both PD and T2W images. All patients except number 9 
had some cerebellar atrophy, particularly involving the 
vermis. Both cerebellar vermis and hemispheres were 
highly atrophic in patient 5, who also showed atrophy of 
the brain stem. A striking finding in all patients except 
numbers 3 and 5 consisted of two symmetrical high signal 
intensity dots in the pontine tegmentum on PD and T2W 
images (figure ID). Pyramidal tracts in pons and mesen­
cephalon were involved in patients 1, 3, 4, and 9. A cavum 
septi pellucidi and cavum vergae of variable size were 
present in all but patients 8 and 9. No signal abnormalities 
were seen in gray-matter structures.
On follow-up, MRI was unchanged in patient 4, showed 
an increase in CSF-like white-matter areas in patients 1,
3, 7, and 9, and showed an increase in cerebellar atrophy 
in patients 1, 5, and 7.
Magnetic resonance spectroscopy. In patients 3, 4, 5, 
and 7, MRS was performed when the disease was in an 
advanced stage. The spectroscopic findings were similar.
Well-defined spectra were obtained from the voxel con­
taining mainly cortex (table 2). The PRESS spectra, ob­
tained with an echo time of 135 msec, showed a decreased
N- acetyl asp art ate (NAA, 2.02 ppm) and a normal ox 
slightly elevated choline level (Cho, 3.21 ppm) relative to 
Cr (3.02 ppm). An inverted doublet was seen centered at 
1.33 ppm with a 7-Hz spin-spin splitting. With use of an 
echo time of 270 msec, the doublet was again in the up­
right position, confirming it to be lactate. Minor signals 
were consistently seen at 3.56 ppm (m/yo-inositol, mlno) 
and at 3.43 and 3.8 ppm (interpreted as glucose). The 
STEAM spectra, obtained with an echo time of 20 msec, 
confirmed the decrease in NAA and the normal or mildly 
elevated level of Cho relative to Cr (figure 3). The relative 
level of mlno was in the normal or low-normal range. In 
patients 3 and 5, very high additional resonances were 
seen at 1.33, 3.43, and 3.8 ppm (see figure 3); in patients 4 
and 7, these peaks were also present, but they were lower.
Only minor resonances were obtained from the white- 
matter voxel in all four patients (figure 4). The peaks of 
NAA, Cho, Cr, and mlno were just discernible within the 
noise. A small lactate doublet was visible at 1.33 ppm. The 
STEAM spectra obtained with an echo time of 20 msec 
showed small additional resonances at 3.43 and 3.80 ppm.
In patient 9, white-matter spectra were obtained soon 
after the onset of neurologic deterioration and revealed 
well-defined peaks of near-normal height. Relative to Cr, 
NAA was mildly decreased and Cho mildly increased. No 
evidence of elevated resonances at 1.33, 3.43, and 3.8 ppm 
was found.
Histopathologic findings. In the case of patient 2, a 
full autopsy was performed. An extensive bronchopneumo­
nia with alveolar hemorrhage and edema was found to 
have affected both lungs. Some hepatic steatosis was 
present. There were bilateral streak ovaria. Otherwise, 
body autopsy findings were unremarkable.
Brain weight was 1,224 grams. External examination of 
the fixed brain revealed some swelling of the surface with 
flattening of gyri. No cingulate or hippocampal herniation 
or grooving was noted. Coronal sections of the brain re­
vealed diffuse abnormality of the cerebral hemispheric 
white matter, which was partly gelatinous and partly cys­
tic (figure 5). A fine meshwork of residual tissue strands 
was observed within some of the cystic areas. Cerebral 
cortex, basal nuclei, thalami, brain stem, and cerebellar 
white matter were macroscopically preserved.
On microscopic examination, the cerebral cortex ap­
peared almost entirely normal with normal neuronal ar-
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Figure 3. STEAM 20 spectra of patient 5 (A) and a nor­
mal control (B), obtained from a cortex voxel. Note that in 
the patient NAA is mildly decreased and Cho is mildly 
increased relative to Cr. There is a high lactate (lac) dou­
blet, Note the highly elevated resonances at 3.43 and 3.80 
ppm , representing glucose (glc), with a contribution of glu­
tamine I glutamate (Glx) at 3.80 ppm .
chitecture and lamination. The cerebral white-matter ab­
normalities started immediately under the cortex, 
although in some areas the U-fibers were partially pre­
served and contained myelin. The white matter between 
the ependymal layer and the U-fibers was largely de­
stroyed, with cystic degeneration progressing from frontal 
to occipital. The integrity of the white matter was best 
preserved in the temporal areas. In those areas of white 
matter that were not completely cystic, there was diffuse 
and severe loss of myelin with spongy alterations (figure 
6A). MBP staining was positive in the lining of vacuoles 
and in many thin fibers. In addition, axonal loss, reactive 
astrocytosis (figure 6B), and macrophage infiltration were
mlno Cho
9lc Cr n a a  lac
—--------- ------ ----- --------- r- ------- 1 —------- - ■ — ------------
4-° 5.0 a.5 i.5 1,0 0,3
Chemical shift / ppm
Figure 4. STEAM 20 spectrum of patient 5, obtained from 
a white-matter voxel. Only minor resonances are discern­
ible at 1.33 ppm (lactate doublet, lac), 2.02 ppm (NAA), 
3.02 ppm (Cr), 3.22 ppm (Cho), 3.43 ppm (glucose, glc), 
3.56 ppm (mlno), and 3.80 ppm (glucose, glc).
present in these areas. Numerous large fibrous astrocytes 
were seen with large extensions (GFAP-positive). Macro­
phages contained punctate, weakly PAS-positive material. 
There was a decrease in the number of oligodendrocytes.
Areas that were less severely affected were the corpus 
callosum, anterior commissure, optic tract, internal cap­
sule, and intrinsic fibers of the thalami. In the caudate 
nucleus, the number of large neurons was decreased. Oth­
erwise, the basal nuclei were normal* In the mesencepha­
lon, the cerebral peduncles were intact, In the pons, the 
volume of the longitudinal fibers was decreased, but there 
was no myelin loss. The ventral trigeminothalamic tract 
and, in particular, the central tegmental tract were se­
verely affected at the level of the pons (figure 7). Within 
the central part of the cerebellar white matter, there were 
areas of myelin loss, but the myelin density within the 
foliae was normal. The dentate nucleus was normal, but 
the hilus of the dentate nucleus was demyelinated. Myelin 
paucity was also observed in the hilus of the inferior olives, 
the pyramids, the spinothalamic tracts, and the corpus 
restiforme. Myelin density was normal in the peripheral 
part of cranial nerves. In the spinal cord, the posterior 
columns were best preserved, though not completely. Mye­
lin density was decreased in the spinocerebellar tracts, the 
lateral and anterior corticospinal tracts, and the anterolat­
eral fascicles containing the spinoreticular and spinotha­
lamic tracts.
Discussion. Disease entity. The clinical pictures 
of the patients and the findings at MRI and MRS are 
strikingly similar. The more severe end of the clini­
cal spectrum is represented by patients 1, 2, 6, and 8, 
who died after an illness lasting several years. Pa­
tients 3 and 4 represent the more benign form, hav­
ing severe neurologic handicap after many years of 
illness. Patients 5 and 7 represent an intermediate 
severity with end-stage neurologic handicap after ill­
ness lasting a considerable number of years. Clini­
cally, the disease is a white-matter disorder with 
prominent ataxia, spasticity, relatively better pre­
served mental capacities, and no or mild epilepsy. 
Optic atrophy may develop, but not always and not 
early. The course of disease is chronic-progressive, 
with episodes of deterioration initiated by minor in­
fections and minor head traumas. There was no evi­
dence of seizure activity or onset of neurologic dete­
rioration preceding a minor head trauma in any of 
the patients. There was never evidence of brain dam­
age directly related to the trauma, in particular no 
evidence of intracranial blood on the MRI performed
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derwent CT at the age of 2 years in the presymptom- 
atic stage. In both patients, extensive cerebral white- 
matter abnormalities were already present. The 
abnormal white matter had a high signal intensity 
on both T2W and PD images. MRI obtained in pa­
tient 9 immediately after onset of somatic neurologic 
deterioration showed that part of the abnormal 
white matter now had a lower signal intensity on PD 
images, though not yet as low as CSF, whereas in his 
severely affected elder sister, part of the white mat­
ter was indistinguishable from CSF. Clinical deterio­
ration in the patients was not associated with more 
extensive white-matter abnormalities, as is the case 
in the “common” demyelinating disorders, but with 
larger areas of already abnormal white matter be­
coming CSF-like. The MRI findings would be com­
patible with primary hypomyelination of the cerebral 
hemispheric white matter, with subsequent degener­
ation and disappearance of all structures within the 
white matter, and replacement by CSF. The progres­
sive cerebellar atrophy, associated with the clinical 
deterioration, occurs in most disorders characterized 
by cerebral neurodegeneration and is not specific.
MRS findings suggest that the cortex is relatively 
well preserved. The mild decrease in NAA suggests 
some neuronal damage and loss.17 In addition, a dou­
blet was centered at 1.33 ppm, representing lactate, 
and two resonances at 3.43 and 3.8 ppm, interpreted 
as glucose.18»19 With glycogen, there should have been 
additional resonances.20’21 Elevation of cortical lac­
tate and glucose probably has pathophysiologic sig­
nificance, but is unexplained. We have not observed 
similar changes in other demyelinating or neuronal 
degenerative disorders. White-matter spectra con­
tained only minor “normal” signals originating from 
remnants of brain tissue, and small “extra” reso­
nances representing lactate and glucose, which are 
normally present in CSF. The white-matter spectra 
are consistent with the presence of mainly CSF and 
little brain tissue.
Histopathology demonstrated an extensively cavi- 
tating leukoencephalopathy. The white matter be­
tween the ependyma and U-fibers had largely disap­
peared and was replaced by CSF. In some areas, 
there was a meshwork of residual tissue strands. In 
areas where the white matter structure was rela­
tively better preserved, signs of myelin loss, spongy 
degeneration, astrogliosis, and macrophage prolifer­
ation and activation were present. On the basis of 
these histopathologic findings, we cannot determine 
whether there was initial hypomyelination, but there 
was definitely a component of active demyelination. 
Based on two brain biopsies, Schiffmann et al.12 con­
cluded that the myelin paucity was a consequence of 
both hypomyelination and demyelination. This con­
clusion would be compatible with our MRI and au­
topsy findings.
Diagnostic criteria. We propose the following cri­
teria for diagnosis of this disease:
(1) Initial psychomotor development is normal or 
only mildly delayed.
(2) Early-childhood onset of neurologic deteriora­
tion with episodic and chronic progressive course. 
Episodes of deterioration may follow infection and 
minor head trauma. Deterioration may lead to leth­
argy or coma.
(3) Neurologic signs mainly consist of cerebellar 
ataxia and spasticity. Optic atrophy may develop but 
is not obligatory. Epilepsy may occur, but is not 
prominent. Mental abilities are relatively better pre­
served than motor functions.
(4) MRI indicates symmetrical involvement of the 
cerebral hemispheric white matter; part or all of the 
white matter has a signal intensity similar to CSF on 
PD, T2W, and TXW images. Cerebellar atrophy varies 
from mild to severe and primarily involves the vermis.
The diagnosis can be made on the basis of these 
four obligatory criteria. MRS can be used as addi­
tional evidence for the disease. White-matter XH MR 
spectra resemble CSF spectra, showing the presence 
of only some lactate and glucose, and the lack of 
most or all normal signals. Cortex spectra maintain 
a more normal appearance, apart from variably ele­
vated lactate and glucose.
These criteria may not allow a definite diagnosis 
in a presymptomatic or early symptomatic stage of 
the disease, unless there is another child with a def­
inite diagnosis within the family. However, until a 
diagnostic biochemical or DNA test is available, the 
diagnosis will eventually be reached with repeat 
MRI (and MRS). We initiated a linkage-analysis 
study to determine the possibility of a DNA-based 
diagnosis.
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Peripheral neuropathy associated 
with sicca complex
Ian A. Grant, MD; Gene G, Hunder, MD; Henry A. Homburger, MD; and Peter J, Dyck, MD
Article abstract—Peripheral neuropathy occurs in Sjogren's syndrome, a disorder in which systemic immunologic 
phenomena, including vasculitis, are common. Neuropathy also occurs with isolated sicca complex (keratoconjunctivitis 
sicca and xerostomia); whether this represents a distinct syndrome is unclear. We retrospectively studied 54 patients with 
sicca complex and peripheral neuropathy to determine mode of presentation, neuropathic patterns, frequency and pattern 
of serologic abnormalities, and frequency of systemic disease, including necrotizing vasculitis. Peripheral neuropathy was 
the presenting problem in 87%. Although sicca symptoms occurred in 93%, they were a presenting complaint in only 11% 
and were usually mild, reported only after specific inquiry. Minor salivary gland biopsy was positive in 73%. Sensory 
neuropathies strongly predominated; 61% of patients manifested either sensory polyneuropathy or polyganglionopathy. 
Less common patterns included sensorimotor polyneuropathy (17%) and polyradiculoneuropathy (11%). Vasculitic neurop­
athy was demonstrated in only two patients, but nonspecific epineurial inflammation was present in 70% of nerve 
biopsies. Clinical evidence of systemic disease was uncommon, particularly in the sensory polyganglionopathy group, in 
whom extragi an dular features other than weight loss occurred in only 1 of 12 patients. Antibodies to extractable nuclear 
antigens, the most specific serologic marker of Sjbgren’s syndrome, were present in 10.4%. We conclude that peripheral 
neuropathy and isolated sicca complex form a distinctive syndrome in which neuropathy is the presenting feature and 
sicca is easily overlooked; sensory polyneuropathy and polyganglionopathy predominate; serology is confirmatory but very 
insensitive; and extraglandular disease, including vasculitis, is uncommon compared with typical Sjogren’s syndrome. 
Tests of ocular or salivary involvement are needed for diagnosis, and demonstration of inflammation in biopsied nerve is 
supportive. Improved definition of this disorder should permit further studies of natural history and efficacy of immuno­
therapy.
NEUROLOGY 1997;48:855-862
Peripheral neuropathy occurs in Sjogren’s syndrome 
(SS), a chronic autoimmune disorder of exocrine
plex (xerophthalmia and xerostomia) related to 
mononuclear infiltration and destruction of lacrimal
glands.1'*'5 The central feature of SS is the sicca com- and salivary glands. However, SS is a systemic dis-
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